Publications
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy2010 | Faculty of Medicine in Hradec Králové
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma +12007 | Faculty of Medicine in Hradec Králové
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma2007 | First Faculty of Medicine
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma2007 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. SGN35-010Publication without faculty affiliation
- Research Report University Hospital for clinical assessment C25003Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: C25003Publication without faculty affiliation
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
Loading network view...